New Delhi, April 26 -- A new study led by cardiologists and policymakers from public healthcare institutes has found that imposing a price cap on coronary stents has helped a higher number of patients from lower-income groups to undergo life-saving procedures. The number of patients who underwent heart procedures with stents rose by 43% after the prices were slashed, according to the study. The findings are significant amid concerns that such price-reduction strategies could compel many foreign players to pull out of the Indian market. As drug-eluting stent (DES) are mostly manufactured by multinational companies, this could lead to decreased use of DES in hospitals, leaving cardiologists with limited options. "Contrary to these concerns, w...